Mortality Risk Prediction in Scleroderma-Related Interstitial Lung Disease
- 1 November 2017
- Vol. 152 (5) , 999-1007
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Clinical characteristics of idiopathic pulmonary fibrosis patients with gender, age, and physiology staging at Okinawa Chubu Hospital2015
- Changes in forced vital capacity over time in systemic sclerosis: application of group-based trajectory modellingRheumatology, 2015
- Predictors of Mortality and Progression in Scleroderma-Associated Interstitial Lung DiseaseChest, 2014
- 6-minute walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosisEuropean Respiratory Journal, 2013
- The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort studyArthritis Research & Therapy, 2013
- Scleroderma lung diseaseEuropean Respiratory Review, 2013
- A Multidimensional Index and Staging System for Idiopathic Pulmonary FibrosisAnnals of Internal Medicine, 2012
- Cigarette smoking in patients with systemic sclerosisArthritis & Rheumatism, 2010
- Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)European Heart Journal, 2009
- MULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORSStatistics in Medicine, 1996